A 34-year-old man with neurofibromatosis type 1, who had received radiation therapy after the excision of a brain tumor 5 years earlier, was admitted to our hospital with vomiting and weight loss. Cortisol and adrenocorticotropin (ACTH)were undetectable before and after administration of 100 (ig corticotropin releasing hormone. The level of growth hormone without stimulation was 24.7 ng/ml. We diagnosed him to have complete ACTHdeficiency attributable to radiation therapy. This is the first knowncase of a patient with complete ACTHdeficiency after radiation therapy and a growth hormone reserve that remained normal. (Internal Medicine 41: 453-457, 2002) 
Introduction
Abnormalities in hypothalamic-pituitary function are known to occur after irradiation for cranial tumors distant from the pituitary gland ( 1-3). Of these abnormalities, growth hormone (GH) deficiency is the most frequent and earliest endocrine dysfunction to occur, followed by gonadotropin deficiency, adrenocorticotropin (ACTH) deficiency, and hypothyroidism (2). Although ACTHdeficiency may develop before GHdeficiency (2, 4), the abnormality is subtle and most patients have normal basal cortisol levels. In this study, we report the first knowncase of a patient with complete ACTHdeficiency and a normal GHreserve 5 vears after radiation therapv for a brain For editorial comment, See p 417.
tumor associated with neurofibromatosis type 1 (NF-1).
Case Report
A 34-year-old man was admitted to our hospital on May18, 2000 with vomiting, general malaise, and poor appetite. These symptoms had begun 2 years earlier and in that time, he had lost 20 kg in weight. According to his medical history, an anaplastic astrocytoma of his left-temporal lobe was resected in September 1994. In March 1 995, he received prophylactic treatment, a 60-Gy total dose of local irradiation. At the time of admission, the patient was 170 cm tall and weighed 39 kg. His body mass index was calculated to be 13.8 kg/m2. His blood pressure was 94/58 mmHg,with a pulse rate of 82/min. Nogoitor or enlargement of lymphnodes was noted. The pubic and axillary hairs were preserved. Seven cafe au lait spots, each greater than 1.5 cm in diameter, were noted on the trunk and extremities, and axillary freckling was present. The remainderof the examinationwasunremarkable.Laboratory findings on admission revealed mild hyponatremia (134 mEq/ /), normochromicanemia, and mild elevation of serum aminotransferase, as shown in Table 1 . A psychiatric evaluation did not support a diagnosis of an eating disorder. After a barium-enema examination, the patient became febrile with frequent vomiting and progressing hyponatremia (125 mEq//). The combination of weight loss, normochromic anemia, and hyponatremia indicated a possibility of adrenal insufficiency and an endocrinological examination was performed. Cortisol and ACTHwere undetectable and the GHlevel was 24.7 ng/ml (Table 1) . Seven days later, further endocrinological examination was performed. Cortisol and ACTH were undetectable before and after administration of 100 jug corticotropin releasing hormone. The GHlevel without stimulation was 2.7 ng/ml and response to GHreleasing hormonewas normal. The prolactin level was high and the response to thyrotropin releasing hormone (TRH)was slightly exaggerated. Stimulation test with luteinizing hormone (LH) releasing hormone showed no response of LHand low response of follicle stimulating hormone (FSH). Thyroid function was normal and thyrotropin response to TRHwas normal (Fig. 1A) . Neither anti-thyroid nor anti-pituitary antibodies were detected. Magnetic resonance imaging (MRI) showed no abnormality except for the thickening of the right optic chiasma, which suggested a diagnosis of an optic glioma (Fig. 2) 
Discussion
Cranial radiation appears to increasingly cause hypothalamic-pituitary dysfunction. Lamet al reported the results of a 5-year longitudinal study on the effect of cranial radiation on the endocrine function (2). Within 2 years of radiation therapy, significant impairment in the secretion of anterior pituitary hormoneswas evident and there was a progressive impairment in pituitary function, leading to hypopituitarism requiring treatment in half of the patients after 5 years. Using life table analysis, the cumulative probability of endocrine dysfunction was estimated to be 62%after 5 years with deficiencies in GH, gonadotropins, ACTH, and TSH found in 63.5, 30.7, 26.7, and 14.9% of patients, respectively. GHdeficiency is the most frequent and earliest endocrine dysfunction to occur after cranial radiation, followed by gonadotropin deficiency, ACTHdeficiency, and hypothyroidism. Furthermore, low doses typically cause isolated GHdeficiency and higher doses cause multiple pituitary deficiencies (5). Thus, GH deficiency generally precedes ACTHdeficiency after cranial radiation. Although ACTH deficiency may develop before GHdeficiency (2, 4), the abnormality is subtle and most patients have normal basal cortisol levels. Assessment of the GH level requires stimulation because of the characteristically pulsatile nature of GH secretion. The insulin tolerance test (ITT) is presently the gold standard for the biochemical diagnosis of GH deficiency (6). However, contraindications to this test include a morning cortisol level of less than 5 [ig/dl, an altered mental status, and generalized debility as in the present case. Normal GH reserve is defined by a peak GH level of greater than 10 ng/ml during the ITT. If this level is achieved, adequate hypoglycemia is not important. In the present case, the GH level without stimulation was 24.7 ng/ml, which indicates normal GH function and no further testing needed. We performed a GH releasing hormone stimulation test as a safe alternative to ITT. A normal GH response to this test suggests a normal GH reserve.
The reason as to why our patient developed complete ACTH deficiency while his GH reserves remained normal is not entirely clear. The threshold dose of radiation that causes GH deficiency appears to be higher in adults than in children and for any given dose of irradiation, the incidence of GH deficiency is lower in adults than in children (7). In contrast, limited data suggest that the incidence ofACTH deficiency may be higher in adults than in children (5). No case of a child whose ACTH deficiency preceded GH deficiency after irradiation is known. In contrast, the case of a 41-year-old man whose partial ACTH deficiency appeared 1 year after irradiation while his GH reserve remained normal has been reported (2). The patient's relatively high age at the time of radiation therapy may be one reason why ACTH deficiency preceded GH deficiency in this case.
It has been reported that meanbasal cortisol levels became significantly lower than pretreatment levels 2 years after radiation therapy (2 in 8 patients (13). However, these cases were all associated with multiple endocrine deficiencies and surgery. Furthermore, most optic gliomas associated with NF-1 appear in the first decade and rarely progress after diagnosis.
In the present patient, the optic glioma has not increased in size from that seen on the MRI taken 5 years earlier. Thus, the optic chiasmal tum or was unlikely to be the primary cause of hypopituitarism.
In summary, this is the first known case of a patient with 
